Prevalence and Predictors of Oral Treponema pallidum Detection by qPCR in Early Syphilis.

Treponema pallidum early syphilis lesion swab oral swab quantitative PCR (qPCR) shedding whole genome sequencing (WGS)

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
21 Dec 2023
Historique:
received: 01 08 2023
revised: 28 11 2023
accepted: 15 12 2023
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

Treponema pallidum (T. pallidum) prevalence and burden at oral and lesion sites in adults with early syphilis were assessed by qPCR. Factors associated with oral shedding were also examined. Pre-treatment oral and lesion swabs were collected from adults with early syphilis in a US multicenter syphilis treatment trial. Oral swabs were collected in the presence and absence of oral lesions. Following DNA extraction, qPCR and whole genome sequencing (WGS) were performed to assess burden and strain variability. All 32 participants were male, mean age was 35, and 90.6% were living with HIV. T. pallidum oral PCR positivity varied by stage: 16.7% primary, 44.4% secondary, and 62.5% in early latent syphilis. Median oral T. pallidum burden was highest in secondary syphilis at 63.2 copies/µL. Lesion PCR positivity was similar in primary (40.0%) and secondary syphilis (38.5%). Age 18-29 years was significantly associated with oral shedding (vs age 40+) in adjusted models. WGS identified two distinct strains. T. pallidum DNA was directly detected at oral and lesion sites in a high proportion of men with early syphilis. Younger age was associated with oral shedding. Ease of oral specimen collection and increased PCR availability suggest opportunities to improve syphilis diagnostic testing.

Sections du résumé

BACKGROUND BACKGROUND
Treponema pallidum (T. pallidum) prevalence and burden at oral and lesion sites in adults with early syphilis were assessed by qPCR. Factors associated with oral shedding were also examined.
METHODS METHODS
Pre-treatment oral and lesion swabs were collected from adults with early syphilis in a US multicenter syphilis treatment trial. Oral swabs were collected in the presence and absence of oral lesions. Following DNA extraction, qPCR and whole genome sequencing (WGS) were performed to assess burden and strain variability.
RESULTS RESULTS
All 32 participants were male, mean age was 35, and 90.6% were living with HIV. T. pallidum oral PCR positivity varied by stage: 16.7% primary, 44.4% secondary, and 62.5% in early latent syphilis. Median oral T. pallidum burden was highest in secondary syphilis at 63.2 copies/µL. Lesion PCR positivity was similar in primary (40.0%) and secondary syphilis (38.5%). Age 18-29 years was significantly associated with oral shedding (vs age 40+) in adjusted models. WGS identified two distinct strains.
CONCLUSION CONCLUSIONS
T. pallidum DNA was directly detected at oral and lesion sites in a high proportion of men with early syphilis. Younger age was associated with oral shedding. Ease of oral specimen collection and increased PCR availability suggest opportunities to improve syphilis diagnostic testing.

Identifiants

pubmed: 38124508
pii: 7485819
doi: 10.1093/infdis/jiad582
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jodie A Dionne (JA)

Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, US.

Lorenzo Giacani (L)

Department of Medicine, Division of Allergy and Infectious Diseases, and Department of Global Health University of Washington, Seattle, WA, US.

Ashutosh Tamhane (A)

Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, US.

Kimberly Workowski (K)

Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, GA, US.

Nicole A P Lieberman (NAP)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, US.

Alexander L Greninger (AL)

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, US.
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, US.

Charlotte Perlowski (C)

FHI 360, Durham, NC, US.

Lori Newman (L)

National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, US.

Edward W Hook (EW)

Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, US.

Classifications MeSH